Furthermore, taking into consideration the reported cooperative network of ACSL1, ACSL4 and SCD and its role in the progression of colorectal cancer, the future direction of the current research will be to test the mutation status of all three genes together and examine the putative association with the expression level of these genes and with clinical outcome in stage II/III CC patients. This evidence concerns the gene ACSL4 and colorectal cancer.